Comparison of calculation algorithms to predict the IQM detector response for various modulation degrees of VMAT treatment plans on linear accelerator equipped with the HD120 MLC.

The calculation model for the integral quality monitor (IQM) system does not take into account the characteristics of the HD120 multileaf collimator (MLC), which some Varian accelerators are equipped with. Some treatment plans prepared with this collimator are characterized by a high level of modulation. The aim of the work was to prepare a model for that collimator and to determine the influence of modulation on results of the verification carried out with the use of IQM system. The short and long stabilities of the IQM detector response were verified by measuring the signal for a 6 MV flattening filter-free (FFF) beam with the static field of 10 × 10 cm2 size. The obtained results were compared with the measurements performed with the PTW Farmer chamber. Next, the signals for 35 static square fields 4 × 4 cm2 , covering the whole field 38 × 20 cm2 , were measured with the IQM. Based on the results of these measurements, the original calculation model has been changed in order to achieve the smallest differences between calculations and measurements. While tuning the model, the characteristics of the HD120 MLC were included. Measurements were performed for 30 clinical plans (86 arcs) prepared with 6 MV FFF beams. Among those 30 plans, there were were multitarget plans with single isocenter. For each plan, the modulation complexity score (MCS) was calculated. The measurement results were compared with the calculation results performed with the original and authors' calculation model. Very good stability of the short and long stabilities of the IQM detector response was obtained. Measurements performed for 35 static fields revealed that for the manufacturer's and for the authors' models, the deviation exceeded 3% for 12 and five of the 35 static fields, respectively. The differences for the manufacturer's and authors' algorithms were in the range of ±2% for the 15 and 26 of the fields, respectively. For original and the authors' models, the differences between measured and calculated signals (starting with the segment number 40) were within the range of ±3.5% for 87.6% and 96.7% of all arcs for the respective models. For both models, the dependence of the compliance of measurements and calculations on the MCS was observed. For most of the very modulated arcs, the measured signal was at least 3% lower than the calculated one. The largest differences between measurements and calculations were obtained for single-isocenter multitarget plans. The signal predicted by an algorithm taking into account the real geometry of the collimating system of the Edge accelerator (equipped with the HD120 MLC) made it possible to obtain greater consistency between the measurements and calculations. We characterized the dependence between the MCS of each arc and the compliance of the measurements and calculations. Much worse results were obtained for single-isocenter multitarget plans.

Janiak PT ，Kukołowicz PF 《-》

Monte Carlo modeling of HD120 multileaf collimator on Varian TrueBeam linear accelerator for verification of 6X and 6X FFF VMAT SABR treatment plans.

Bergman AM ，Gete E ，Duzenli C ，Teke T ... -  《Journal of Applied Clinical Medical Physics》

Feasibility of a GATE Monte Carlo platform in a clinical pretreatment QA system for VMAT treatment plans using TrueBeam with an HD120 multileaf collimator.

To evaluate the quality of patient-specific complicated treatment plans, including commercialized treatment planning systems (TPS) and commissioned beam data, we developed a process of quality assurance (QA) using a Monte Carlo (MC) platform. Specifically, we constructed an interface system that automatically converts treatment plan and dose matrix data in digital imaging and communications in medicine to an MC dose-calculation engine. The clinical feasibility of the system was evaluated. A dose-calculation engine based on GATE v8.1 was embedded in our QA system and in a parallel computing system to significantly reduce the computation time. The QA system automatically converts parameters in volumetric-modulated arc therapy (VMAT) plans to files for dose calculation using GATE. The system then calculates dose maps. Energies of 6 MV, 10 MV, 6 MV flattening filter free (FFF), and 10 MV FFF from a TrueBeam with HD120 were modeled and commissioned. To evaluate the beam models, percentage depth dose (PDD) values, MC calculation profiles, and measured beam data were compared at various depths (Dmax , 5 cm, 10 cm, and 20 cm), field sizes, and energies. To evaluate the feasibility of the QA system for clinical use, doses measured for clinical VMAT plans using films were compared to dose maps calculated using our MC-based QA system. A LINAC QA system was analyzed by PDD and profile according to the secondary collimator and multileaf collimator (MLC). Values for MC calculations and TPS beam data obtained using CC13 ion chamber (IBA Dosimetry, Germany) were consistent within 1.0%. Clinical validation using a gamma index was performed for VMAT treatment plans using a solid water phantom and arbitrary patient data. The gamma evaluation results (with criteria of 3%/3 mm) were 98.1%, 99.1%, 99.2%, and 97.1% for energies of 6 MV, 10 MV, 6 MV FFF, and 10 MV FFF, respectively. We constructed an MC-based QA system for evaluating patient treatment plans and evaluated its feasibility in clinical practice. We observed robust agreement between dose calculations from our QA system and measurements for VMAT plans. Our QA system could be useful in other clinical settings, such as small-field SRS procedures or analyses of secondary cancer risk, for which dose calculations using TPS are difficult to verify.

Lee B ，Jeong S ，Chung K ，Yoon M ，Park HC ，Han Y ，Jung SH ... -  《Journal of Applied Clinical Medical Physics》

Sensitivity of the IQM transmission detector to errors of VMAT plans.

The integral quality monitor (IQM) transmission detector is a wedge-shaped large area ionization chamber that reports a position-weighted dose area product for each control point of an IMRT or VMAT plan. In this study, the accuracy of the signal prediction is verified for the Synergy Agility MLC. Tolerance criteria for VMAT plan verification with the IQM were obtained from the observed sensitivity for the detection of incorrectly delivered plans. The predicted IQM signal was compared to the measured signal recorded for a set of 30 VMAT plans for each beam quality of 6 and 10 MV. The system's capability to detect incorrectly delivered plans was tested by measuring altered plans containing small, random deviations. In addition, the observed deviations were related to measurements performed with a second QA phantom. The cumulative IQM signal per arc deviated from the respective calculation on average by -0.48% (6 MV) and +0.21% (10 MV) with a standard deviation of 1.08% in both cases, suggesting a 2% warning and 3% action threshold as plan acceptance criteria. This choice was confirmed by the optimum threshold of 2.5% obtained via receiver operating characteristic (ROC) analysis. Reproducibility of individual control points in multiply measured plans was low (on average 7% for 1SD) and thus, segment-by-segment comparison was impractical. A suitable criterion to resolve the angular distribution of the plan was identified by binning three to five control points as a running average. While the correlation between IQM signal deviations and gamma passing rates obtained with the ArcCHECK phantom was low for clinical plans, it was apparent for erroneous plans. Binning led to even higher sensitivity to errors. The IQM was able to detect induced errors at least as reliable as the standard phantom and showed the potential to be used in pretreatment plan verification to ensure the correct plan transfer and delivery. However, there is no direct correlation between the IQM signal deviation and DVH metrics, so the IQM should be primarily used to screen for errors. Finer diagnostics should then be carried out using a different phantom.

Razinskas G ，Wegener S ，Greber J ，Sauer OA ... -  《-》

An investigation of the IQM signal variation and error detection sensitivity for patient specific pre-treatment QA.

To evaluate the Integral Quality Monitor (IQM) as a clinical dosimetry device for detecting photon beam delivery errors in clinically relevant conditions. The IQM's ability to detect delivery errors introduced into clinical VMAT plans for two different treatment sites was assessed. This included measuring 103 nasopharynx VMAT plans and 78 lung SBRT VMAT plans with introduced errors in gantry angle (1-5°) and in MLC-defined field size and field shift (1-5 mm). The IQM sensitivity was compared to ArcCheck detector performance. Signal dependence on field position for on-axis and asymmetrically offset square field sizes from 1 × 1 cm2 to 30 × 30 cm2 was also investigated. The IQM detected almost all introduced clinically-significant MLC field size errors, but not some small gantry angle errors or most MLC field shift errors. The IQM sensitivity was comparable to the ArcCheck for lung SBRT, but worse for the nasopharynx plans. Differences between IQM calculated/predicted and measured signals were within ± 2% for all on-axis square fields, but up to 60% for the smallest asymmetrically offset fields at large offsets. The IQM performance was consistent and reproducible. It showed highest sensitivity to the field size errors for these plans, but did not detect some clinically-significant introduced gantry angle errors or most MLC field shift errors. The IQM calculation model is still being developed, which should improve small offset-field performance. Care is required in IQM use for plan verification or online monitoring, especially for small fields that are off-axis in the detector gradient direction.

Alharthi T ，George A ，Arumugam S ，Holloway L ，Thwaites D ，Vial P ... -  《-》